
Work Here?
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$57.6M
Headquarters
Washington DC, District of Columbia
Founded
2018
Sorcero provides an AI-powered platform for the life sciences industry that unifies and analyzes medical data from both public sources and internal CRMs, helping medical affairs teams stay productive and aligned. Its core offering, the Sorcero Intelligence Platform, uses medical language intelligence to organize structured and unstructured data in a cloud-based, B2B system. It supports regulatory compliance through Sorcero SciComms, which is designed to meet EMA, ICH, and FDA requirements, and has launched specialized AI Agents for Life Sciences to deliver more accurate insights. The platform uses a siloed tenanted architecture to keep each client’s data secure. Sorcero differentiates itself by focusing on medical language understanding, regulatory-aligned insights, and seamless data unification across multiple sources for medical affairs teams. The company aims to improve productivity, align strategies, and ensure compliant, trustworthy insights for life sciences organizations.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$57.6M
Above
Industry Average
Funded Over
4 Rounds
Industry standards
Paid Vacation
Paid Sick Leave
Paid Holidays
Parental Leave
Sorcero has launched Field Medical Excellence & Insights and Congress Intelligence solutions to help life sciences companies accelerate evidence-based medical affairs strategies. The AI-powered platform includes a new Capture App for iPad and integration of 3.5 million scientific abstracts from over 4,300 global conferences dating back to 2010. The solutions address medical affairs teams' struggle with fragmented data from CRM notes, advisory boards and publications. Sorcero claims its platform cuts weekly reporting time by over 72% and reduces ad hoc analysis time by up to 90%. The Field Medical solution enables medical science liaisons to capture and analyse healthcare professional interactions, whilst Congress Intelligence automates conference analysis and delivers post-event insights immediately. The company will showcase both solutions at MAPS Americas 2026 conference from 22-25 March.
From the Field to the future: Sorcero reinvents Field Medical Excellence & Insights and Congress Intelligence. As the Sorcero team is gearing up to join thousands of medical affairs professionals at MAPS Americas 2026, one theme is clear: the industry is ready to move past fragmented data and into a new era of evidence-driven intelligence. At Sorcero, Sorcero, Inc. has spent the last year listening to the challenges MSLs and Medical Affairs leaders face every day. This week, Sorcero, Inc. is thrilled to introduce two major solutions of the Sorcero Medical(TM) product suite designed to bolster scientific exchange and strategic impact with its Field Medical Excellence & Insights and Congress Intelligence solutions. Check out the press release and keep reading to get the deep dive! Solution Spotlight: Field Medical Excellence & Insights The Field Medical Excellence & Insights solution allows MSL teams to capture, surface, and share high-impact insights from HCP interactions in real time to directly inform medical strategy. The AI-powered platform automatically extracts emerging trends from field notes to allow measurement of engagement effectiveness against therapeutic objectives. By putting MSLs at the heart of multiple sources of potential insight, it allows for the personalization and focused analysis of themes and questions to inform precision Field Medical engagement. Collaborative validation workflows and interactive dashboards allow leaders to see higher quality and timely insights, enabling them to drill down into individual source notes without manual CRM searches. MSLs and leadership teams can now shift away from operational work to high-level strategic thinking. Teams can proactively identify educational gaps, improve insight capture efficiency, and demonstrate the qualitative value and strategic importance of their engagements directly to leadership. Say Goodbye to the Capture Gap and Hello to Sorcero's Capture App For too long, the industry has accepted a capture gap. A Medical Science Liaison can have a groundbreaking conversation with a Key Expert but if they put off capturing critical details due to the complexity of documentation, they often get lost completely. When you have to wait to get back to a desktop CRM or struggle with a clunky mobile web experience, insights become blurry. The Sorcero Capture App This is exactly why Sorcero, Inc. built the Sorcero Capture App. This app allows field-based personnel to quickly record key observations directly from their iPad. These submissions become part of a central, structured insight repository that lives alongside your CRM data. * Streamlined Mobile Entry: MSLs can enter rich text notes and associate records with specific HCPs directly from their tablets without having to navigate dozens of dropdown fields to manually tag every entry. * Robust Offline Support: The app stores data locally and syncs automatically in the background once connectivity is restored, ensuring no insight is lost in transit. * Instant AI Enrichment: These submissions are immediately tagged for Intelligent Medical Themes(TM) and analyzed for Scientific Sentiment(TM) to ensure consistency across the organization. | The MSL Perspective Having just completed her last meeting of the day, she takes a few minutes to type the notes from the exchange into the Capture App taking care to reflect the words used by the Dr as they described their treatment objectives, challenges and what additional data they felt was needed and why. A few clicks and the draft is saved to submit now or later. She remembers how in the past it was a struggle to decide which topic the wide ranging conversation best fit under in the CRM but is now satisfied that the themes will be automatically picked up and become part of the evidence seen tomorrow by the Insights Lead. For many MSLs, the feeling that the voice of the HCPs they work with is not heard clearly at the strategy level is a real concern. Collaboration with these experts is based on trust that when an expert takes the time to share, those views will drive better patient outcomes. Now MSLs are not merely the conduit for communication but also the conductor of strategic attention to deliver on the promises these conversations hold. Accurately captured opinion, need, and commentary from HCPs are plugged straight into strategy-changing insight evidence collections. They are flagged directly in the analytical environment seen by all levels of Medical Affairs rather than discussed in monthly internal meetings with limited attendance. MSLs and strategic leaders now see how the detailed and "clinician-voice" notes from scientific exchange exponentially increase the quality of what the AI has to summarize and uncover trends from. | It's Time to Connect the Dots: Congress Intelligence Scientific congresses are the heartbeat of Medical Affairs, yet the learnings gathered there are notoriously scattered across slide decks, personal emails, and physical notebooks. By the time you bring all the information together, the insights may have already changed. Sorcero's Congress Intelligence solution revolutionizes how Medical Affairs teams engage at scientific conferences by providing an end-to-end platform for automated analysis. The solution enables teams to perform comprehensive pre-congress planning by instantly summarizing and enriching thousands of abstracts to build targeted KOL engagement lists based on topic relevance. During the live event, the platform provides daily monitoring of late-breaking results and presentation updates, uncovering personalized daily highlights that prioritize onsite engagements and are tailored to specific strategic imperatives. The Sorcero Congress Abstract Data Integration As a part of its focus to make MSLs lives easier, the Congress Intelligence solution automatically integrates congress abstracts into the Sorcero Scientific Data Pool. This provides centralized, searchable access to 3.5 million abstracts and posters from over 4,300 global conferences. The team can also track grey literature produced outside of traditional publishing and distribution channels as well as historical research data dating back to 2010, uncovering critical evidence often years before it appears in peer-reviewed journals. This isn't just a database, it's intelligence that allows for richer pre- and post-congress analytics alongside your existing data. That means your team can plan outreach with surgical precision, prioritize which posters to see based on real-time evidence, and drive targeted follow-ups that reference exactly what was discussed on the floor. | Strategy at Scale Preparation ahead of a congress has always been a crucial task to make the most of these unique data release opportunities. Pouring over congress websites as the abstracts are released becomes an eyewatering task of looking for keywords that indicate strategic relevance and spotting names of known experts. Absorbed in the task of deciding who to meet with, which sessions to cover and posters to read, it is easy to forget what a professor has presented in previous years, and how their current case series links to their comments about where the treatment pathway was heading in last summer's Ad board, and instead see a reductionist view of just the congress ahead. Bringing all those sources of information together allows contextual analysis of why a symposium is pushing boundaries of care, or how a poster is exploding a treatment paradigm and enables deeper exploration of the connections between researchers with the same scientific aims. | A Complete Intelligence Loop With the Field Medical Excellence & Insights and Congress Intelligence solutions, the Sorcero Medical(TM) product suite is a game changer for medical affairs. Imagine identifying an emerging trend in a set of new medical congress abstracts, recording an KOL's reaction to that data during a chance meeting in the exhibit hall, having these insights systematically bubble up to leadership, and then informing strategy at a regional and global field level in days instead of months. This isn't just about collecting data; it's about creating a repeatable, measurable source of truth. It's also a vital tool for field and congress activities, ensuring that the investment your company makes in these resources translates into long-term strategic value. Join Us in the Mile High City Sorcero, Inc.'d love to show you these tools in action. If you're in Denver for MAPS Americas 2026, come visit the Sorcero team at Booth #126. Sorcero, Inc. can discuss how these innovations can be tailored to your therapeutic area. Let's move beyond simply "capturing" data and start commanding it. Can't make it to the booth? Follow Sorcero, Inc. on LinkedIn for live updates from the floor or Schedule a Demo to see Sorcero in action. Vic ho. VP, Medical Strategy and Solutions
citybiz+ ai-driven medical sciences platform Sorcero closes $42M Series B, Blu Venture among investors. Washington, D.C.-based Sorcero, which runs an AI-driven intelligence platform for medical sciences, has closed a $42 million Series B funding round led by Radnor, Pa.-based NewSpring Growth. Other investors included Vienna, Va.-based Blu Venture Investors and Kansas' Leawood Venture Capital. So far, the three-year-old startup has raised $59 million. Sorcero was founded by the duo of Dipanwita Das, who has previously worked for Virgin's Richard Branson and former Vice President Al Gore, and MIT's Walter Bender, who has spent nearly 50 years as a research scientist. Das, who serves as the company's CEO, is an alumna of Stanford Graduate School of Business and has studied in India, the United Kingdom and the United States. Founded in 1999 by Michael DiPiano and Marc Lederman, NewSpring has invested in over 200 companies. Today, it manages over $3.5 billion across five distinct strategies, ranging from growth equity and control buyouts to mezzanine debt. DiPiano serves as the firm's managing general partner, while Lederman is a general partner. NewSpring runs a family of private equity funds, the most recent of which, NewSpring Health Capital IV, closed in 2024 after raising over $180 million. Blu Venture Investors, founded in 2010, has invested over $100 million in about 175 startups, many of which focus on SaaS and technology ventures. Its recent investments included Procurement Sciences, InnerActiv, Trially, Returnalyze and Prediction Guard. The Sorcero Intelligence Platform comprises Sorcero Medical, Sorcero Medtech, Sorcero Safety, and Sorcero SciComms. The platform is used by pharmaceutical companies to identify actionable findings from medical data and enable engagement with healthcare professionals. Its knowledge databases encompass medical device, medical affairs, safety and scientific communications sectors. The company plans to use the funding for global expansion of its SaaS platform. "Our vision is to create a unified intelligence platform for the precision medicine era. We're pioneering a new evidence-based medical affairs model where science, personalized for physicians, drives engagement and product adoption," said Das. "This puts doctors' evidence needs at the center and helps life sciences generate real-world insights radically faster, identify patients in need of specific treatments, and continually improve patient outcomes to drive healthcare provider adoption." Sorcero claims its platform helps raise users' productivity in the generation of scientific evidence by as much as 92%, expediting the generation of insights by up to 72%, and delivering manuscripts, evidence, and value dossiers two to five months quicker when compared with manual processes. The platform integrates several sources to provide a broad view of more than 40 million healthcare professionals and 100 million published scientists globally.
Sorcero has raised $42.5 million in Series B funding led by NewSpring Growth, with participation from Leawood Venture Capital and Blu Ventures, bringing its total capital raised to $59 million. The funding will help Sorcero expand its AI platform across medical affairs, safety, scientific communications, and medical device segments globally. Sorcero's platform is used by one-third of the top 30 global pharma companies to accelerate insight generation and improve patient outcomes.
Sorcero secures $42.5M Series B financing led by NewSpring Capital to scale its AI platform, accelerate expansion across life sciences. WASHINGTON, Nov. 21, 2025 /PRNewswire/ - Sorcero, the AI-powered intelligence platform for life sciences, today announced $42.5 million in Series B financing led by NewSpring Growth, NewSpring Capital's dedicated growth equity strategy that invests in fast-growing, industry-transforming technology companies. They are joined by Leawood Venture Capital and Blu Ventures, bringing the company's total capital raised to $59 million. The latest funding allows Sorcero to accelerate expansion across medical affairs, safety, scientific communications, and medical device segments globally, continue scaling its platform for a medical-insights driven engagement model, and meet life sciences' critical need to drive adoption of breakthrough therapies. One-third of the top 30 global pharma companies use Sorcero to discover actionable insights from their medical data and drive effective evidence-based, personalized engagement with healthcare professionals (HCPs). Using Sorcero, companies are improving productivity in generating scientific evidence by up to 92%, accelerating insight generation by up to 72%, and delivering published evidence, manuscripts, and value dossiers two to five months faster than manual efforts. The Sorcero Intelligence Platform includes Sorcero Medical(TM), Sorcero SciComms(TM), Sorcero Safety(TM), Sorcero Medtech(TM), transforming how therapies get to market, accelerating content production, and improving patient outcomes. Sorcero uniquely combines Agentic AI specifically trained for life sciences, the industry's largest medically-enriched data pool, and a platform architecture designed for regulatory and privacy needs of life sciences. "Our vision is to create a unified intelligence platform for the precision medicine era," said Dipanwita Das, CEO and co-founder at Sorcero. "We're pioneering a new evidence-based medical affairs model where science, personalized for physicians, drives engagement and product adoption. This puts doctors' evidence needs at the center and helps life sciences generate real-world insights radically faster, identify patients in need of specific treatments, and continually improve patient outcomes to drive healthcare provider adoption." Precision medicine and specialty drugs now represent over 80% of new approved products. Companies spend billions on research and development, but new complex medicines take years to secure broad adoption and coverage, with effective therapies often failing to reach eligible patients. With over 1,300 drugs in Phase III development and with 76% of new products securing less than 50% payor coverage in six months, quality and speed-to-market of scientific publishing and evidence are critical and medical affairs teams require new approaches to deliver the precision targeting and evidence today's therapies require.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$57.6M
Headquarters
Washington DC, District of Columbia
Founded
2018
Find jobs on Simplify and start your career today